摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methanamine, N-[(2-methylphenyl)methylene]-, (E)- | 53699-35-7

中文名称
——
中文别名
——
英文名称
Methanamine, N-[(2-methylphenyl)methylene]-, (E)-
英文别名
o-tolualdehyde N-methylimine
Methanamine, N-[(2-methylphenyl)methylene]-, (E)-化学式
CAS
53699-35-7
化学式
C9H11N
mdl
——
分子量
133.193
InChiKey
QIHXQRVPVMCYEO-JXMROGBWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    210.5±19.0 °C(Predicted)
  • 密度:
    0.87±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.04
  • 重原子数:
    10.0
  • 可旋转键数:
    1.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    12.36
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    N,N-二乙基-2-甲基苯甲酰胺Methanamine, N-[(2-methylphenyl)methylene]-, (E)-lithium diisopropyl amide 作用下, 生成 2-Methyl-3-o-tolyl-3,4-dihydro-2H-isoquinolin-1-one
    参考文献:
    名称:
    Synthesis of 3-substituted and 3,4-disubstituted 3,4-dihydro-1(2H)-isoquinolones by condensation of lithiated N,N-diethyl-o-toluamide with imines
    摘要:
    DOI:
    10.1021/jo00233a013
  • 作为产物:
    描述:
    2-甲基苯甲醛甲胺 反应 15.0h, 以90%的产率得到Methanamine, N-[(2-methylphenyl)methylene]-, (E)-
    参考文献:
    名称:
    Syntheses of polycyclic ring systems based on the new generation of o-quinodimethanes
    摘要:
    DOI:
    10.1021/ja00390a036
点击查看最新优质反应信息

文献信息

  • AGGREGATION-INDUCED EMISSION LUMINOGENS FOR METAL ION DETECTION
    申请人:TANG Benzhong
    公开号:US20130059392A1
    公开(公告)日:2013-03-07
    Pyridine-containing polyenes and their applications as metal ion sensors. These polyenes are practically nonluminescent in the solution state but become highly emissive as nanoparticle suspensions in aqueous solutions or thin films in the solid state, due to aggregation-induced emission (AIE). The nanoaggregates of these compounds can work as “turn-off” fluorescent chemosensors for metal ions and display different fluorescence responses to various metal ions. For example, a characteristic red shift in the emission spectra is observed with a terpyridine-containing luminogen in the presence of Zn 2+ . However, the terpyridine-containing luminogen displays a magenta color upon selectively binding with Fe 2+ . This allows easy identification of both Zn 2+ and Fe 2+ ions in aqueous media. The function of the polyenes can be easily tuned by altering the substituent groups. Due to their AIE properties, these polyenes can be used in aqueous solutions and in solid substrates for metal sensing.
    含吡啶基的聚烯烃及其作为金属离子传感器的应用。这些聚烯烃在溶液状态下几乎不发光,但当作为纳米颗粒悬浮液存在于水溶液中或以薄膜形式存在于固态中时,由于聚集诱导发光(AIE)而变得高度发光。这些化合物的纳米聚集体可以作为金属离子的“关闭”荧光化学传感器,并对各种金属离子显示不同的荧光响应。例如,在存在Zn2+时,富含三吡啶的发光剂的发射光谱中观察到特征性的红移。然而,当与Fe2+选择性结合时,富含三吡啶的发光剂显示品红色。这使得在水介质中轻松识别Zn2+和Fe2+离子成为可能。通过改变取代基,可以轻松调节聚烯烃的功能。由于其AIE特性,这些聚烯烃可用于水溶液和固体基质中的金属传感。
  • (PYRROLIDIN-2-YL)PHENYL DERIVATIVES
    申请人:Grove Simon James Anthony
    公开号:US20100113493A1
    公开(公告)日:2010-05-06
    The invention relates to (pyrrolidin-2-yl)phenyl derivatives having the general Formula I wherein R 1 is (C 1-4 )alkyl, halo(C 1-4 )alkyl, (C 1-4 )alkyloxy, or halo(C 1-4 )alkyloxy; R 2 is H, (C 1-4 )alkyl, halo(C 1-4 )alkyl, (C 1-4 )alkyloxy, halo(C 1-4 )alkyloxy or halogen; R 3 is H, (C 1-4 )alkyl or halo(C 1-4 )alkyl; R 4 is H, (C 1-4 )alkyl or halo(C 1-4 )alkyl; R 5 is H, (C 1-4 )alkyl or halo-(C 1-4 )-alkyl; or R 4 and R 5 , when bonded to the same carbon atom, can together with the carbon atom form a spiro(C 3-6 )cycloalkyl group, optionally substituted with halogen; R 6 is H, (C 1-4 )alkyl, halo(C 1-4 )alkyl, (C 1-4 )alkyloxy, halo(C 1-4 )alkyloxy or halogen; or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of these (pyrrolidin-2-yl)phenyl derivatives for the treatment of pain, such as neuropathic pain or inflammatory pain.
    该发明涉及具有通式I的(吡咯啉-2-基)苯基衍生物,其中R1为(C1-4)烷基、卤代(C1-4)烷基、(C1-4)烷氧基或卤代(C1-4)烷氧基;R2为H、(C1-4)烷基、卤代(C1-4)烷基、(C1-4)烷氧基、卤代(C1-4)烷氧基或卤素;R3为H、(C1-4)烷基或卤代(C1-4)烷基;R4为H、(C1-4)烷基或卤代(C1-4)烷基;R5为H、(C1-4)烷基或卤代(C1-4)烷基;或者当R4和R5与同一碳原子结合时,它们可以与碳原子一起形成一个可选择地取代卤素的螺环(C3-6)环烷基基团;R6为H、(C1-4)烷基、卤代(C1-4)烷基、(C1-4)烷氧基、卤代(C1-4)烷氧基或卤素;或其药学上可接受的盐,以及含有这些(吡咯啉-2-基)苯基衍生物的药物组合物,以及这些(吡咯啉-2-基)苯基衍生物用于治疗疼痛,如神经痛或炎症性疼痛。
  • NOVEL PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS
    申请人:Rhizen Pharmaceutical SA
    公开号:US20150087699A1
    公开(公告)日:2015-03-26
    The present invention relates to compounds useful as pharmaceutical intermediates, to processes for preparing the intermediates, to intermediates used in the processes, and to the use of the intermediates in the preparation of pharmaceuticals. In particular, the present invention concerns enantiomerically pure optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives represented by formula (IA) and (IB), processes for preparing the alcohol derivatives and their use in preparing pharmaceuticals.
    本发明涉及作为药物中间体有用的化合物,用于制备中间体的过程,用于这些过程中使用的中间体,以及在制备药物中使用这些中间体。具体来说,本发明涉及对映纯的可选取代的2-(1-羟基-烷基)-香豆素衍生物,其表示为式(IA)和(IB),制备醇衍生物的过程以及它们在制备药物中的使用。
  • PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS
    申请人:Rhizen Pharmaceuticals SA
    公开号:US20170266196A1
    公开(公告)日:2017-09-21
    The present invention relates to compounds useful as pharmaceutical intermediates, to processes for preparing the intermediates, to intermediates used in the processes, and to the use of the intermediates in the preparation of pharmaceuticals. In particular, the present invention concerns enantiomerically pure optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives represented by formula (IA) and (IB), processes for preparing the alcohol derivatives and their use in preparing pharmaceuticals.
    本发明涉及用作制药中间体的化合物,制备中间体的过程,用于过程的中间体以及中间体在制备制药品中的应用。特别地,本发明涉及旋光纯的可选取代的2-(1-羟基-烷基)-香豆素衍生物,其化学式为(IA)和(IB),制备醇衍生物的过程以及它们在制备制药品中的应用。
  • Synthetic studies on the lithiated toluamide-imine cycloaddition route to (.+-.)-corydalic acid methyl ester
    作者:Robin D. Clark、Jahangir
    DOI:10.1021/jo00266a033
    日期:1989.3
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐